These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 33877951
21. The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis. Tripathi M, Kaushik S, Dubey P. J Postgrad Med; 2003; 49(4):311-4; discussion 314-5. PubMed ID: 14699228 [Abstract] [Full Text] [Related]
23. Case Report: Ocular Myasthenia Gravis Associated with In Vitro Fertilization Procedures. Yoo YJ, Han SB, Yang HK, Hwang JM. Optom Vis Sci; 2018 May; 95(5):475-478. PubMed ID: 29683988 [Abstract] [Full Text] [Related]
25. Development of generalized disease at 2 years in patients with ocular myasthenia gravis. Kupersmith MJ, Latkany R, Homel P. Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710 [Abstract] [Full Text] [Related]
26. Ice pack test: is it obsolete? Rajasekharan C, Anishkumar V, Suresh MK. BMJ Case Rep; 2011 Jul 28; 2011():. PubMed ID: 22689834 [Abstract] [Full Text] [Related]
28. Clinical predictors for the prognosis of myasthenia gravis. Wang L, Zhang Y, He M. BMC Neurol; 2017 Apr 19; 17(1):77. PubMed ID: 28420327 [Abstract] [Full Text] [Related]
29. Ophthalmologic clinical features of ocular myasthenia gravis. Kim DH, Roh HC, Oh SY. Medicine (Baltimore); 2023 Jan 13; 102(2):e31972. PubMed ID: 36637960 [Abstract] [Full Text] [Related]
33. The case of the droopy eye. Ocular myasthenia gravis. Wang H, Brown-Harrell V. Postgrad Med; 1999 Dec 02; 106(7):87-8, 91. PubMed ID: 10608966 [No Abstract] [Full Text] [Related]
34. Age of onset and factors affecting treatment responses in ocular myasthenia gravis. Kemchoknatee P, Armornpetchsathaporn A, Tangon D, Srisombut T. Int Ophthalmol; 2023 Aug 02; 43(8):2777-2785. PubMed ID: 36879110 [Abstract] [Full Text] [Related]
35. Myasthenia gravis: an unusual cause of diplopia in polymyalgia rheumatica. Fernández-Castro M, Andreu JL, Muñoz P, Ornilla E. Clin Exp Rheumatol; 2004 Aug 02; 22(4):505. PubMed ID: 15301257 [No Abstract] [Full Text] [Related]
37. Depression: A Contributing Factor to the Clinical Course in Myasthenia Gravis Patients. Mihalache OA, Vilciu C, Petrescu DM, Petrescu C, Manea MC, Ciobanu AM, Ciobanu CA, Popa-Velea O, Riga S. Medicina (Kaunas); 2023 Dec 28; 60(1):. PubMed ID: 38256317 [Abstract] [Full Text] [Related]
38. Ocular myasthenia gravis: a review and practical guide for clinicians. Shuey NH. Clin Exp Optom; 2022 Mar 28; 105(2):205-213. PubMed ID: 35157811 [Abstract] [Full Text] [Related]
39. Effect of treatment with Fufang Huangqi decoction on dose reductions and discontinuation of pyridostigmine bromide tablets, prednisone, and tacrolimus in patients with type I or II myasthenia gravis. Caifeng S, Jingsheng Z, Yi L, Xueshi H, Zhanyou W, Haiou P, Wenjun Q. J Tradit Chin Med; 2022 Oct 28; 42(5):810-817. PubMed ID: 36083490 [Abstract] [Full Text] [Related]